Product Images Novoseven RT
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 43 images provide visual information about the product associated with Novoseven RT NDC 0169-7205 by Novo Nordisk, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
NovoSeven RT is a medication used to treat bleeding episodes in people with hemophilia A or B. It is a recombinant form of factor VIIa, which helps the blood to clot. NovoSeven RT is typically administered during surgery or after an injury to prevent excessive bleeding. It is not available over the counter and must be prescribed by a medical professional.*
This is a description of a 10 mmol solution of Histidine used for reconstitution of NovoSeven® RT 2 mg. It should be stored between 2-25°C (36-77°F) and has an NDC of 0169-7012-98. There is also a Lot No. of 8-9033-31-201-2 with an Exp. Date listed. This product is only available with a prescription (Rxonly).*
This is a description of a medicine called Histidine that is used to reconstitute a drug called NovoSeven RT 5 mg. The medicine comes in a 10 mmol solution and has a National Drug Code (NDC) of 0169-7015-98. It should be stored at a temperature between 2-25°C (36-77°F) and requires a prescription to obtain. The text also includes manufacturer/lot number information and an expiration date.*
This is a description of a medication called NovoSeven® RT with the active ingredient Coagulation Factor Vila (Recombinent). It is a room temperature stable medication that is administered through intravenous injection. It should be stored between temperatures of 2-25°C (36-77°F) and reconstituted with 5 mL histidine diluent only. The label indicates that it is for prescription-only use and provides contact information for the manufacturer, Novo Nordisk Inc. There is also an expiration date and lot number provided on the label.*
NOC OO T218-11 is a product by Novo Nordisk Inc called NovoSeven RT. It is a coagulation factor Vil (Recombinant) and is stored at room temperature between 2-25°C (36-77°F). It is meant for bolus intravenous administration and should be reconstituted with 8 mL histidine diluent mentioned as IPLH. The expiration date is mentioned in the form of Lot No. The contact number is provided as 1877:NOVO-777 16.*
This is a description of a diluent vial labelled "Power vl". The vial has a plastic cap and a rubber stopper. There are two sets of plastic caps and rubber stoppers present in the image.*
This is a document related to chemical composition and identification. The document mentions the use of Histidine solution and Novoseven medication. It also provides a code or identification number (Noc 168700298) and some information on storage conditions. The remaining text looks like product information, including expiration date and lot number.*
This is a description of a medication product. The product is a 10 mmol solution of Histidine used for the reconstitution of NovoSeven® RT 5 mg. The medication should be stored at a temperature between 2-25°C (36-77°F) and is available only with a prescription. The product is distributed by Novo Nordisk Inc. and the expiration date is mentioned as 8.9316-31:2031.*
This is a description of a medication called NovoSeven® RT. It requires reconstitution with a 10 mmol solution of Histidine in order to be used. The medication should be stored between 2-25°C (36-77°F) and its NDC (National Drug Code) is 0169-7011-98. There is also a lot number provided by the manufacturer, Novo Nordisk Inc. The text does not provide further information than this.*
This appears to be a product label or packaging information for a medication or solution made by Novo Nordisk Inc. The product is stored at room temperature and is meant for "bels iirvensus sdministration". It is instructed to be stored between 2.25°C and G67T. The product may come with a "cuion with 11 mL" but it is unclear what this means. The text also includes an expiration date (Date/lot no) of 12-31-2021.*
This is a description of a drug with the NDC number 01697027 11 that can be reconstituted using 21 ml dime diluent. The drug is stable at room temperature and is intended for intravenous administration. It should be stored between 2 and 25°C by Novo Nordisk Inc. The expiration date and lot number are also provided.*
This is a description of NovoSeven® RT, a recombinant Coagulation Factor Vila that is room temperature stable. It is administered through bolus intravenous and stored between 2-25°C (36-77°F) following reconstitution with 5.2 mL 2-25°C (36-77°F) histidine diluent only TR. The product comes with an Rx only prescription label and the manufacturer's contact number 1-877-NOVO-777. The expiration date of the product is given as 89014312021.*
This is a product label for a solution of Histidine, which is meant to be stored between 2-25°C (36-77°F). The label includes the National Drug Code (NDC) and the manufacturer's information (Novo Nordisk Inc.). The product is meant for reconstitution and is only available with a prescription. The label also provides an expiration date and lot number.*
This is a product description for Histidine, a 10 mmol solution used to reconstitute NovoSeven RT 8mg. It is only available with a prescription and should be stored between 2-25°C. The text also provides information on the manufacturer, Novo Nordisk Inc., and a lot number, but no discernible expiry date is available.*
NovoSeven RT is a recombinant coagulation factor used for the treatment of bleeding in patients with hemophilia A or B, or with acquired hemophilia.*
NovoSeven® RT is a medication used for the treatment of bleeding in individuals with congenital hemophilia A or B, or who have developed inhibitors to clotting factors VIII or IX. It contains Coagulation Factor VIIa (Recombinant) and is administered intravenously.*
NovoSeven® RT is a medication used for treating bleeding episodes and controlling bleeding during surgery. It contains the active ingredient Coagulation Factor VIIa (Recombinant).*
This appears to be a list of components included in a package containing NovoSeven® RT powder for injection. The package includes a vial of the powder, a vial adapter, a pre-filled syringe with diluent, a plunger rod, a plastic cap, a protective cap, a rubber plunger, a rubber stopper, a storage paper, and a syringe cap.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.